Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05584553 · ClinicalTrials.gov registry record

PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm and JuggerLoc™ in the Shoulder

A clinical trial, sponsored by Zimmer Biomet.

Completed
Registry status
214
Enrollment target

NCT05584553 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 214 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05584553 has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
214 participants
Enrollment target

Study Summary

The study is a multicenter, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect data confirming safety, performance and clinical benefits of the ToggleLoc 2.9 mm and the JuggerLoc Soft Tissue Systems when used for soft tissue to bone fixation in the shoulder. The primary objective is the assessment of performance by analyzing soft tissue to bone healing in the shoulder. The secondary objective is the assessment of safety and clinical benefits. Safety will be evaluated by recording and analyzing the incidence and frequency of complications and adverse events. Relation of the events to device, instrumentation and/or procedure will be specified. Clinical benefits will be assessed by recording patient-reported outcome measures (PROMs) at the longest follow-up after surgery (minimum one year).

Interventions

  • DEVICE ToggleLoc 2.9 mm soft tissue device
  • DEVICE JuggerLoc soft tissue device

Trial Details

FieldValue
Enrollment Target 214 participants
Start Date 2022-12-02
Est. Completion 2024-06-30

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT05584553

The ClinicalTrials.gov registry entry for NCT05584553 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ToggleLoc 2.9 mm soft tissue device is the first listed.

NCT05584553 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05584553 about?

NCT05584553 is a clinical study titled "PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm and JuggerLoc™ in the Shoulder". The study is a multicenter, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect data confirming safety, performance and clinical benefits of the ToggleLoc 2.9 mm and the JuggerLoc Soft Tissue Systems when used for soft tissu...

What is the current status of trial NCT05584553?

This trial is currently completed. The enrollment target is 214 participants. The study started on 2022-12-02. Estimated completion is 2024-06-30.

What interventions are being tested in trial NCT05584553?

The interventions under investigation include: ToggleLoc 2.9 mm soft tissue device (DEVICE), JuggerLoc soft tissue device (DEVICE).

Who is sponsoring clinical trial NCT05584553?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.